Ferring today published its latest Annual Report which shows the company reported revenues of €2,162 million, +11% at AER, +14% at CER and a record level of Net Income at €290 million up +91% AER. These results reflect the company’s strong and leading position in the field…

Ferring has announced key leadership appointments to ensure it is well-placed to deliver on the next exciting phase of its growth strategy. This includes developing and launching new therapies in the field of reproductive medicine and maternal health and other specialty areas of medicine such as…